Clinical trial
Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera
NCT02832323 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera
- Lead sponsor
- University Hospital, Brest
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 22, 2016
- Completion date
- June 30, 2021
- Enrollment
- 94 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.